Dangerous Drug News

Side Effect Information About Dangerous Drugs and Medical Devices

Altrumedia
  • Home
  • About
  • Dangerous Drug News
  • Drugs
    • Fluoroquinolone Antibiotics
    • Pradaxa
    • Proton Pump Inhibitors
    • Risperdal
    • Talcum Powder
    • Taxotere
    • Xarelto
    • Zofran
  • Medical Devices
    • Essure
    • IVC Filters
    • Power Morcellators
    • Transvaginal Mesh
  • Free Case Evaluation

Risperdal

Risperdal (risperidone) is a second-generation antipsychotic, also known as an atypical antipsychotic. It is approved for treatment of treat schizophrenia, bipolar disorders, and autism spectrum disorders. It has also been prescribed off-label to treat attention deficit hyperactivity disorder (ADHD) in children. Risperdal has been linked to numerous serious side effects, including gynecomastia, the development of male breasts.

Risperdal Uses

The U.S. Food and Drug Administration (FDA) approved Risperdal for the following to treat the following:

  • Schizophrenia in adults and adolescents
  • Bipolar disorder in adults and adolescents
  • Autism spectrum disorder in children and adolescents

Off-label refers to uses that are not approved by the FDA. Risperdal has been prescribed off-label to treat conditions including:

  • ADHD
  • Anxiety
  • Depression
  • Dementia

Off-Label Marketing

Doctors are allowed to prescribe drugs off-label when they believe it is in the best interests of their patients. It is illegal for drug companies to market their drugs for off-label uses. On November 4, 2013, the U.S Department of Justice (DOJ) announced that Johnson & Johnson (J&J) and its subsidiaries would pay more than $2.2 billion in criminal and civil penalties to resolve allegations of off-label marketing of drugs including Risperdal and paying kickback to doctors and a large pharmacy.

Risperdal Side Effects

Risperdal has been linked to the following side effects and injuries:

  • Gynecomastia
  • Movement disorders
  • Pituitary tumors
  • Stroke in elderly patients
  • Diabetes
  • Pancreatitis
  • Heart Problems
  • Neuroleptic malignant syndrome (NMS)
  • Priapism
  • Weight gain
  • Vomiting

Gynecomastia

Risperdal has been linked to gynecomastia, when taken by boys. Gynecomastia is the development of male breasts. Risperdal use can result in elevated levels of the hormone prolactin. In females, prolactin stimulates the production of milk during pregnancy and nursing. In males, elevated prolactin causes excessive growth of breast tissue. This is not merely the growth of larger breasts due to excess fat. It is actual breast tissue which can only be corrected surgically.

Studies have found that gynecomastia can cause serious and long-term trauma to boys including damage to their:

  • Self esteem
  • Mental health
  • Social functioning

Surgery to correct gynecomastia can be serious and carries substantial risks. Complications and permanent injuries from gynecomastia correction surgery can include:

  • Infections
  • Changes in sensation
  • Painful scarring
  • Disfigurement
  • Asymmetry

 

Share this:

  • Facebook
  • LinkedIn
  • Twitter

RSS FDA Med Watch

  • Sandoz Inc. Issues Voluntary Nationwide Recall of One Lot of Cefazolin for Injection Due to Product Mispackaging
  • Angiographic Catheter Recall: Cook Removes Beacon Tip Angiographic Catheters due to Tip Separation
  • mRNA COVID-19 Vaccines: FDA Safety Communication - FDA Approves Required Updated Warning in Labeling Regarding Myocarditis and Pericarditis Following Vaccination
  • Early Alert: Esophageal pH Monitoring Capsule Issue from Medtronic
  • Flexible Tracheostomy Tube Recall: Medtronic Removes Shiley Adult Flexible Tracheostomy Tube with TaperGuard Cuff Reusable Inner Cannula Due to Risk for Disconnection of the Flange from the Device Cannula
  • Import Alerts for Certain Olympus Medical Devices Manufactured in Japan - Letter to Health Care Providers
  • Medical Procedure Kits Correction: Medline Industries, LP Issues Correction for Medline Procedure Kits Containing Medtronic Aortic Root Cannula due to Potential Excess Material in Male Luers

Recent Headlines

Diabetic Man Testing Blood Levels

Type 2 Diabetes Drugs Pose Numerous Health Risks

The hits just keep coming for Johnson & Johnson, and now its … [Read More...]

PPIs Side Effects

PPI Heartburn and Ulcer Medications May Cause Stomach Cancer

Proton pump inhibitors (PPIs) are used to treat heartburn, … [Read More...]

Johnson & Johnson Loses Second Major Talcum Powder Case

In its second trial loss in less than 3 months, Johnson & … [Read More...]

Find an Attorney

RSS US Recall News

  • Belviq Withdrawn Due to Cancer Risk
  • Common Heartburn Medication may lead to bladder, stomach, and other cancers. Zantac Lawsuits begin.
  • J&J Settles Talc Mesothelioma Settlement

RSS Lawsuits and Settlements

  • Possible Lawsuit: Suboxone Tooth Decay Legal News and Lawsuit Information
  • Possible Lawsuit: Ozempic and Mounjaro Weight Loss Lawsuit News and Legal Information
  • Possible Lawsuit: CPAP Lung Cancer Lawsuit News and Legal Information

RSS Mass Tort News

  • An error has occurred, which probably means the feed is down. Try again later.

RSS Health Industry

  • Feds Prevail Over J&J In Another 340B Rebate Dispute
  • DC Circ. Backs NLRB Ruling In GWU Hospital Bargaining Case
  • Sam's Club Lifting Work Caused Miscarriage, Ex-Worker Says

ABOUT US

DRUG INFO

DEVICES

CASE REVIEW

NEWS

Copyright © 2025 DangerousDrugNews.com · Site Map - Website Development by Altrumedia · Log in